Rhino-orbito-cerebral mucormycosis in new-onset type 1 diabetes mellitus: a case-based short review

Isabella Sharifi1, Alejandra Razzeto1, Susana Barreiro Sacco1

  • 1Division of Endocrinology, Department of Internal Medicine, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA.

Insights

Mucormycosis, a severe fungal infection, particularly affects patients with diabetic ketoacidosis (DKA). Early diagnosis and treatment, including surgery and antifungal drugs, are crucial for survival in diabetic patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Endocrinology

Background:

  • Mucormycosis is an aggressive angioinvasive fungal infection.
  • Patients with diabetic ketoacidosis (DKA) are uniquely susceptible.
  • Hyperglycemia and acidosis in DKA enhance fungal invasion and impair immune defenses.

Purpose of the Study:

  • To review the epidemiology, pathogenesis, diagnosis, and management of rhino-orbito-cerebral mucormycosis.
  • To highlight the importance of prompt recognition and multidisciplinary care in diabetic patients.
  • To discuss emerging diagnostic and therapeutic developments.

Main Methods:

  • Case vignette presentation.
  • Review of current literature on mucormycosis in diabetic patients.
  • Discussion of diagnostic tools and treatment strategies.

Main Results:

  • Rapid recognition, urgent surgical debridement, and prompt high-dose liposomal amphotericin B are essential.
  • Reversal of metabolic derangements is a cornerstone of care.
  • Newer antifungals like isavuconazole and posaconazole show promise for step-down therapy.

Conclusions:

  • Outcomes in mucormycosis are time-dependent.
  • Clinicians should suspect invasive fungal sinusitis in diabetic patients with DM.
  • Multidisciplinary evaluation and timely intervention are critical for improved patient outcomes.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...